相关实验视频
Updated: Jul 12, 2025

03:36
Development of Compendium for Esophageal Squamous Cell Carcinoma
Published on: April 12, 2024
465
识别与肺腺癌中的PANoptosis相关的预后基因,并根据生物信息学分析开发基于预测模型
Chi Zhang1, Jiangnan Xia2, Xiujuan Liu1
1Oncology Department, Dongfang Hospital, Beijing University of Chinese Medicine, Beijing, China.
Scientific reports
|October 20, 2023
概括
一个新的六基因模型通过分析PANoptosis调节器来预测肺腺癌 (LUAD) 患者的预后. 该模型识别出具有不良结果和改变免疫反应的高风险群体,有助于癌症研究.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 免疫学 免疫学 免疫学
背景情况:
- 与细胞死亡相关的基因对于癌症患者的预后至关重要.
- 一种新的细胞死亡途径PANoptosis与癌症和免疫有关,但它在肺腺癌 (LUAD) 中的作用尚不清楚.
研究的目的:
- 为了阐明在LUAD中PANoptosis的意义.
- 为LUAD患者开发基于PANoptosis调节器的预后风险预测模型.
主要方法:
- 从公共数据库中对mRNA基因表达和临床数据的系统分析.
- 使用基因表达总 (GEO) 数据库构建和验证一个六基因风险预测模型.
- 定量逆转录聚合酶链反应 (qRT-PCR) 用于验证肺癌细胞中的基因表达.
主要成果:
- 一个六个基因的签名 (NLRC4,FADD,TRADD,RIPK1,PSTPIP2,MLKL) 准确地预测了LUAD患者的预后.
- 高风险组和集群2与预后不佳,免疫透分子减少和人类白细胞抗原表达相关.
- 与PANoptosis相关的基因 (PRG) 显示出明显的表达模式和与体质突变,瘤免疫功能障碍,干性和免疫透相关的相关性.
结论:
- 开发的六基因风险特征是估计LUAD患者预后的可靠工具.
- 该研究强调了PANoptosis调节器作为LUAD中的生物标志物和治疗点的潜力.
- 进一步的分析探索了签名在名录构造,分层和预测对药物和化疗反应的实用性.
相关概念视频
Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K
lncRNA - Long Non-coding RNAs
8.6K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.6K
Cancer-Critical Genes I: Proto-oncogenes
8.9K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.9K

